Eltrombopag and high-dose dexamethasone as frontline treatment of newly diagnosed immune thrombocytopenia in adults

ITP: hematology's Cosette from Les Miserables

(2013) V. K. Rao   BLOOD

Rituximab and dexamethasone vs dexamethasone monotherapy in newly diagnosed patients with primary immune thrombocytopenia

(2013) S. Gudbrandsdottir et al.   BLOOD

Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group

(2013) F. Rodeghiero et al.   BLOOD

High response rate to low-dose rituximab plus high-dose dexamethasone as frontline therapy in adult patients with primary immune thrombocytopenia

(2013) David Gómez-Almaguer et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Pathophysiology and management of primary immune thrombocytopenia

(2013) Hirokazu Kashiwagi et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Sustained remissions of immune thrombocytopenia associated with the use of thrombopoietin receptor agonists

(2013) Bahareh Ghadaki et al.   TRANSFUSION

Health-related quality of life in nonsplenectomized immune thrombocytopenia patients receiving romiplostim or medical standard of care

(2012) David J. Kuter et al.   AMERICAN JOURNAL OF HEMATOLOGY

Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND study

(2012) M. N. Saleh et al.   BLOOD

Repeated short-term use of eltrombopag in patients with chronic immune thrombocytopenia (ITP)

(2012) James B. Bussel et al.   BRITISH JOURNAL OF HAEMATOLOGY

The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia

(2011) C. Neunert et al.   BLOOD

Newly diagnosed immune thrombocytopenia in children and adults: a comparative prospective observational registry of the Intercontinental Cooperative Immune Thrombocytopenia Study Group

(2011) T. Kuhne et al.   HAEMATOLOGICA

Advances in ITP – Therapy and Quality of Life – A Patient Survey

(2011) Axel C. Matzdorff et al.   PLoS One

Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia

(2010) F. Zaja et al.   BLOOD

Improved regulatory T-cell activity in patients with chronic immune thrombocytopenia treated with thrombopoietic agents

(2010) W. Bao et al.   BLOOD

Pathophysiology and management of chronic immune thrombocytopenia: focusing on what matters

(2010) Lisa J. Toltl et al.   BRITISH JOURNAL OF HAEMATOLOGY

Low-dose rituximab combined with short-term glucocorticoids up-regulates Treg cell levels in patients with immune thrombocytopenia

(2010) Zhenyu Li et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study

(2010) Gregory Cheng et al.   LANCET

International consensus report on the investigation and management of primary immune thrombocytopenia

(2009) D. Provan et al.   BLOOD

Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group

(2008) F. Rodeghiero et al.   BLOOD